BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27638745)

  • 1. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.
    Nensa F; Kloth J; Tezgah E; Poeppel TD; Heusch P; Goebel J; Nassenstein K; Schlosser T
    J Nucl Cardiol; 2018 Jun; 25(3):785-794. PubMed ID: 27638745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of fusion
    Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
    J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.
    Rischpler C; Langwieser N; Souvatzoglou M; Batrice A; van Marwick S; Snajberk J; Ibrahim T; Laugwitz KL; Nekolla SG; Schwaiger M
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):661-9. PubMed ID: 25680385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis.
    Hanneman K; Kadoch M; Guo HH; Jamali M; Quon A; Iagaru A; Herfkens R
    Clin Nucl Med; 2017 Jul; 42(7):e328-e334. PubMed ID: 28418949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.
    Kataoka S; Momose M; Fukushima K; Serizawa N; Suzuki A; Kondo C; Abe K; Sakai S; Hagiwara N
    Ann Nucl Med; 2017 Feb; 31(2):135-143. PubMed ID: 27804054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography in clinically suspected myocarditis - STREAM study design.
    Ozierański K; Tymińska A; Kobylecka M; Caforio ALP; Šobić-Šaranović D; Ristić AD; Maksimović R; Seferović PM; Marcolongo R; Królicki L; Opolski G; Grabowski M
    Int J Cardiol; 2021 Jun; 332():113-118. PubMed ID: 33657398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/
    Tanaka TD; Nagai T; Nagoshi T; Yoshimura M
    J Nucl Cardiol; 2020 Dec; 27(6):2149-2153. PubMed ID: 31773564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study.
    Treiber J; Novak D; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Weferling M; von Jeinsen B; Hain A; Rieth AJ; Siemons T; Keller T; Hamm CW; Rolf A
    J Cardiovasc Magn Reson; 2023 Feb; 25(1):8. PubMed ID: 36755275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
    Adhaduk M; Paudel B; Khalid MU; Ashwath M; Mansour S; Liu K
    J Nucl Cardiol; 2023 Aug; 30(4):1574-1587. PubMed ID: 36443587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography.
    Chan AT; Fox J; Perez Johnston R; Kim J; Brouwer LR; Grizzard J; Kim RJ; Matasar M; Shia J; Moskowitz CS; Steingart R; Weinsaft JW
    J Am Heart Assoc; 2019 May; 8(10):e011709. PubMed ID: 31072171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid PET/MR imaging of the heart: feasibility and initial results.
    Nensa F; Poeppel TD; Beiderwellen K; Schelhorn J; Mahabadi AA; Erbel R; Heusch P; Nassenstein K; Bockisch A; Forsting M; Schlosser T
    Radiology; 2013 Aug; 268(2):366-73. PubMed ID: 23651530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.
    Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Ntusi N; Holloway C; Choudhury RP; Kardos A; Robson MD; Friedrich MG; Neubauer S
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1048-1058. PubMed ID: 24011774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis.
    Peretto G; Busnardo E; Ferro P; Palmisano A; Vignale D; Esposito A; De Luca G; Campochiaro C; Sartorelli S; De Gaspari M; Rizzo S; Dagna L; Basso C; Gianolli L; Della Bella P; Sala S
    JACC Cardiovasc Imaging; 2022 Oct; 15(10):1771-1780. PubMed ID: 36202457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of
    Kaushik P; Patel C; Gulati GS; Seth S; Parakh N; Randeep Guleria ; Kumar R; Gupta P; Bal C
    Ann Nucl Med; 2021 Sep; 35(9):1058-1065. PubMed ID: 34125376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
    Hatipoglu S; Gardezi SKM; Azzu A; Baksi J; Alpendurada F; Izgi C; Khattar R; Kouranos V; Wells AU; Sharma R; Wechalekar K; Pennell DJ; Mohiaddin R
    Heart; 2023 Apr; 109(10):748-755. PubMed ID: 36627181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of Assessing Inflammation in Asymptomatic Abdominal Aortic Aneurysms With Integrated 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging.
    Kuzniar M; Tegler G; Wanhainen A; Ahlström H; Mani K; Hansen T
    Eur J Vasc Endovasc Surg; 2020 Mar; 59(3):464-471. PubMed ID: 31708339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.